Although the influence of immune response is still unclear in GISTs, studies have identified that the expression level of PD-1 and PD-L1 is high in most GIST samples, which means the immune checkpoints and their relationship with the clinical phenotype of GISTs are becoming potential prognostic biomarkers. The gene discussed is CD274; the disease is gastrointestinal stromal tumor.